Major Review Finds Alzheimer’s Amyloid Drugs Offer No Real Benefit
A major review challenges a long-standing strategy in Alzheimer’s research, suggesting that removing a hallmark brain protein may not lead to meaningful improvements for patients. A major new Cochrane review…